Why 2020 Is the Time to Feel Better
You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!
- How many people with migraine speak to a health professional?
- Why are so few people with migraine disease working with a health professional?
- When was migraine first described and what were some early treatments?
- What are the options for migraine treatment?
- What is a migraine treatment map?
- What factors can we control?
- What role is there for lifestyle management and education, and what are some examples?
- What are behavioral therapies for migraine?
- What emerging therapies are there in the behavioral treatment field?
- Which pharmaceutical treatments are commonly used?
- What are interventional approaches to migraine?
- What is neuromodulation, and what options are available?
- What is integrative medicine?
- What are some examples of complementary therapies?
- If you’ve given up, where do you find the motivation to keep trying?
- What does self-care really mean?
Dawn C. Buse, PhD
Psychologist & Clinical Professor
Albert Einstein College of Medicine
Dawn C. Buse, PhD, is a clinical professor of neurology at Albert Einstein College of Medicine, a member of the board of directors of the American Headache Society, and a licensed psychologist. She has authored more than 200 scientific publications and has won eight U.S. and international research awards and four professional awards for her work in the field of migraine.
She is a co-investigator on numerous U.S. and international studies, including the American Migraine Prevalence and Prevention (AMPP) study, the Chronic Migraine Epidemiology and Outcomes (CaMEO) study, the Migraine Signature Study (MSS), the International Burden of Migraine Study (IBMS), the Migraine in America Symptoms and Treatment (MAST) study, the Observational Survey of the Epidemiology, Treatment and Care of Migraine (OVERCOME) study, and the FDA-sponsored Migraine Clinical Outcome Assessment System (MiCOAS) grant, which is gathering patient input for the development of migraine clinical trial endpoints. She is an advocate for the well-being of patients and healthcare professionals.
Watch at your own pace & get up to 24% off when you purchase the 2023 Migraine World Summit before March 8. Includes:
- All expert interviews with seperate audio (MP3) files & transcripts
- 30 extended, uncut interview editions with 6.5 hours of bonus expert footage
- Lifetime access with no annual fee